Central Serous Retinopathy (CSR): Symptoms, Causes, and Treatment Options

Central Serous Chorioretinopathy (CSCR): Overview and Management

Central serous chorioretinopathy (CSCR) is characterized by serous neurosensory retinal detachment due to focal leakage through the retinal pigment epithelium (RPE), typically at the macula. It predominantly affects men aged 20–50 and is strongly associated with stress and corticosteroids.

Risk Factors and Triggers

  • Male sex (M:F ~6:1)
  • Psychological stress / Type A personality
  • Exogenous corticosteroids (oral, topical, inhaled, injected) – major iatrogenic trigger
  • Endogenous cortisol elevation (Cushing's, pregnancy)
  • Sleep deprivation, shift work
  • Helicobacter pylori infection (association)
  • Genetic variants (CFH, HTRA1, NR3C2)

Symptoms

  • Central or paracentral scotoma (gray/blind spot)
  • Blurred or distorted vision (metamorphopsia)
  • Micropsia (objects appear smaller)
  • Reduced color saturation / contrast sensitivity
  • Relative hyperopic shift (farsightedness)
  • Often unilateral; bilateral in ~10–15%

Diagnostic Imaging

  • OCT (Optical Coherence Tomography): Serous subretinal fluid, RPE elevation, hyperreflective foci; hallmark sign
  • Fundus autofluorescence (FAF): Granular hyper/hypoautofluorescence at leak sites
  • Fluorescein angiography (FA): "Inkblot" or "smokestack" leakage pattern
  • Indocyanine green angiography (ICGA): Choroidal hyperpermeability, dilated choroidal vessels

Natural History

  • Acute: 80–90% resolve spontaneously within 3–6 months
  • Recurrence: 20–50% in same or fellow eye
  • Chronic CSCR (>6 months): RPE atrophy, photoreceptor loss, persistent vision impairment

Treatment

Observation (First-line for acute, good vision)

  • Discontinue corticosteroids if possible
  • Stress reduction, sleep optimization
  • Monitor q1–3 months with OCT

Laser Photocoagulation

  • Focal laser to leak point (outside fovea) – accelerates resolution; risk of scotoma if near fovea
  • Subthreshold micropulse laser – safer for subfoveal leaks; less collateral damage

Photodynamic Therapy (PDT)

  • Verteporfin + low-fluence laser; targets choroidal hyperpermeability
  • Standard for chronic/subfoveal CSCR; may need repeat
  • Risk: photosensitivity, choroidal ischemia

Medical Therapy (Investigational/Off-label)

  • Mineralocorticoid receptor antagonists: Eplerenone, spironolactone – promising RCTs
  • Anti-VEGF (aflibercept, ranibizumab) – limited evidence; for CNV complication
  • Beta-blockers, melatonin, rifampicin – anecdotal/small studies

Lifestyle Modifications

  • Stress management (CBT, mindfulness, exercise)
  • Adequate sleep (7–9 hours)
  • Avoid exogenous steroids (all routes) if possible
  • Smoking cessation
  • Limit alcohol

Key Takeaway

CSCR is often self-limited, but chronic/recurrent cases risk permanent vision loss. Early diagnosis with OCT, corticosteroid avoidance, stress management, and timely intervention (micropulse laser, PDT) preserve visual function. Collaborate with a retina specialist for personalized care.

Eye & Vision Disorders - Related Articles